Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 7,500 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS) insider Michael Chi sold 7,500 shares of Hims & Hers Health stock in a transaction dated Monday, October 21st. The stock was sold at an average price of $22.20, for a total value of $166,500.00. Following the sale, the insider now directly owns 193,980 shares of the company’s stock, valued at $4,306,356. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Michael Chi also recently made the following trade(s):

• On Thursday, August 1st, Michael Chi sold 2,054 shares of Hims & Hers Health stock. The shares were sold at an average price of $22.00, for a total value of $45,188.00.

Hims & Hers Health Stock Up 2.3 %

Shares of HIMS traded up $0.54 on Tuesday, reaching $23.59. The stock had a trading volume of 7,393,755 shares, compared to its average volume of 8,200,775. The firm has a market capitalization of $5.07 billion, a PE ratio of -2,359.00 and a beta of 1.06. The firm has a 50-day moving average of $17.08 and a 200 day moving average of $17.67. Hims & Hers Health, Inc. has a twelve month low of $5.65 and a twelve month high of $25.74.

Hims & Hers Health (NYSE:HIMS) last released its quarterly earnings results on Monday, August 5th. The company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. The business had revenue of $315.65 million for the quarter, compared to analysts’ expectations of $302.43 million. Hims & Hers Health had a return on equity of 5.25% and a net margin of 1.70%. The company’s revenue was up 51.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.03) EPS. On average, sell-side analysts anticipate that Hims & Hers Health, Inc. will post 0.22 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on HIMS. Jefferies Financial Group boosted their target price on Hims & Hers Health from $14.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, June 27th. Needham & Company LLC began coverage on Hims & Hers Health in a report on Thursday, August 22nd. They issued a “buy” rating and a $24.00 target price for the company. Piper Sandler reissued a “neutral” rating and issued a $18.00 target price on shares of Hims & Hers Health in a report on Tuesday, August 6th. Imperial Capital downgraded Hims & Hers Health from an “outperform” rating to an “in-line” rating in a research note on Friday, August 9th. Finally, Bank of America upped their price objective on Hims & Hers Health from $23.00 to $25.00 and gave the company a “buy” rating in a research note on Monday. Eight analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.21.

Institutional Investors Weigh In On Hims & Hers Health

Institutional investors and hedge funds have recently modified their holdings of the company. CWM LLC grew its holdings in Hims & Hers Health by 21.4% during the 3rd quarter. CWM LLC now owns 5,982 shares of the company’s stock valued at $110,000 after buying an additional 1,054 shares during the last quarter. Arizona State Retirement System grew its holdings in Hims & Hers Health by 3.0% during the 2nd quarter. Arizona State Retirement System now owns 40,344 shares of the company’s stock valued at $815,000 after buying an additional 1,173 shares during the last quarter. Victory Capital Management Inc. grew its holdings in Hims & Hers Health by 6.6% during the 2nd quarter. Victory Capital Management Inc. now owns 19,469 shares of the company’s stock valued at $393,000 after buying an additional 1,212 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in Hims & Hers Health by 679.2% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after buying an additional 1,603 shares during the last quarter. Finally, Swiss National Bank grew its holdings in Hims & Hers Health by 0.7% during the 1st quarter. Swiss National Bank now owns 281,500 shares of the company’s stock valued at $4,355,000 after buying an additional 2,000 shares during the last quarter. Institutional investors and hedge funds own 63.52% of the company’s stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.